在牛皮和牛皮关节炎的治疗进展
Robin C Yi1, Maya Akbik2, Logan R Smith1
1Center for Dermatology Research, Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA.
Journal of clinical medicine
|February 26, 2025
概括
牛皮和牛皮性关节炎 (PsA) 的新疗法正在出现,包括生物药物和口服小分子. 目前正在进行的研究探讨了解决未满足需求的新型治疗方法,平衡有效性与安全性,以提供个性化的患者护理.
科学领域:
- 皮肤病学和免疫学
- 药理学和治疗学 药理学和治疗学
背景情况:
- 牛皮和牛皮性关节炎 (PsA) 管理已经推进了新的局部,口服系统和生物疗法.
- 针对瘤坏死因子-α (TNF-α),互白蛋白 (IL-12/23,IL-17,IL-23) 和口服小分子,如Janus 激酶 (JAK) 和氨酸激酶2 (TYK2) 抑制剂的生物药物提供了有效的替代品.
研究的目的:
- 审查目前和新兴的牛皮和牛皮性关节炎 (PsA) 治疗方法.
- 评估新型治疗方案是否解决现有治疗方法中未得到满足的需求.
主要方法:
- 使用PubMed,谷歌学者和临床试验.gov.gov进行文献搜索.
- 包含相关文章和正在进行的临床试验,使用特定的关键词.
主要成果:
- 许多针对牛皮和PsA的新疗法正在临床试验中,包括选择性JAK抑制剂,TYK2抑制剂,RORγT抑制剂,口服IL-23受体和IL-17A抑制剂,纳米体,S1P1R对抗剂,A3AR激动剂,HSP90抑制剂和ROCK-2抑制剂.
- 这些药物具有多种作用机制,可能有利于那些对当前疗法反应不足的患者.
结论:
- 新兴疗法扩大了牛皮和PsA的治疗选择,但安全性和禁忌需要仔细考虑患者选择和降低风险.
- 目前正在进行的研究重点是提高疗效,长期安全性和患者喜欢的输送方法,口服IL-23抑制剂在安全性方面表现有前景,而口服IL-17和TYK-2抑制剂需要仔细管理副作用.
- 平衡疗效,安全性和患者偏好对于指导最佳治疗选择至关重要.
相关概念视频
Inflammatory Bowel Disease IV: Pharmacological Management
89
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
89
T Cell Types and Functions
796
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
796
Drug Therapy
34
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
34
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
107
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
107
EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
iPS Cell Differentiation
2.6K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.6K


